SCHEMBL7715922

SCHEMBL7715922

N#Cc1ccccc1N1CCC(NCC(N)=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 6/20 0.47
DRD2 P14416 5/20 0.47
CHRM4 P08173 1/20 0.45
ALDH1A1 P00352 2/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
GRM5 P41594 1/20 0.44
DRD3 P35462 4/20 0.44
GAA P10253 1/20 0.43
KDM4E B2RXH2 3/20 0.43
RECQL P46063 1/20 0.43
PDCD1 Q15116 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
MEN1 O00255 1/20 0.42
CYP2C9 P11712 1/20 0.42
XBP1 P17861 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7717203 0.93 DRD2 (0.43) DRD4DRD2CHRM4ALDH1A1POLB
SCHEMBL7716779 0.83 CHRM4 (0.47) CHRM4DPP4DPP8DPP9MTOR
SCHEMBL31042542 0.82 DRD4 (0.45) DRD4DRD2CHRM4ALDH1A1POLB
SCHEMBL7711167 0.82 NPC1 (0.56) ALDH1A1MAPTKDM4EPDCD1CD274
SCHEMBL7714987 0.80 KDM4E (0.44) DRD4DRD2CHRM4ALDH1A1GRM5
SCHEMBL31042529 0.80 CHRM4 (0.50) DRD4DRD2CHRM4ALDH1A1POLB
SCHEMBL20149778 0.80 DRD4 (0.43) DRD4DRD2CHRM4ALDH1A1GRM5
SCHEMBL8003101 0.79 DRD4 (0.42) DRD4GAAKDM4E
SCHEMBL31042527 0.79 DRD4 (0.51) DRD4DRD2CHRM4ALDH1A1POLB
SCHEMBL7715013 0.79 KDM4E (0.44) ALDH1A1KDM4EPDCD1CD274CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376503-B1 TREATMENT OF BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC 2002-04-23 US disclosed